Exportar Publicação

Freitas, C., Reis, V., Silva, S., Videira, P. A., Morava, E. & Jaeken, J. (2017). Public and patient involvement in needs assessment and social innovation: a people-centred approach to care and research for congenital disorders of glycosylation. BMC Health Services Research. 17

C. S. Freitas et al.,  "Public and patient involvement in needs assessment and social innovation: a people-centred approach to care and research for congenital disorders of glycosylation", in BMC Health Services Research, vol. 17, 2017

@article{freitas2017_1732241804545,
	author = "Freitas, C. and Reis, V. and Silva, S. and Videira, P. A. and Morava, E. and Jaeken, J.",
	title = "Public and patient involvement in needs assessment and social innovation: a people-centred approach to care and research for congenital disorders of glycosylation",
	journal = "BMC Health Services Research",
	year = "2017",
	volume = "17",
	number = "",
	doi = "10.1186/s12913-017-2625-1",
	url = "https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-017-2625-1"
}

TY  - JOUR
TI  - Public and patient involvement in needs assessment and social innovation: a people-centred approach to care and research for congenital disorders of glycosylation
T2  - BMC Health Services Research
VL  - 17
AU  - Freitas, C.
AU  - Reis, V.
AU  - Silva, S.
AU  - Videira, P. A.
AU  - Morava, E.
AU  - Jaeken, J.
PY  - 2017
SN  - 1472-6963
DO  - 10.1186/s12913-017-2625-1
UR  - https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-017-2625-1
AB  - Background: Public and patient involvement in the design of people-centred care and research is vital for communities whose needs are underserved, as are people with rare diseases. Innovations devised collectively by patients, caregivers, professionals and other members of the public can foster transformative change toward more responsive services and research. However, attempts to involve lay and professional stakeholders in devising community-framed strategies to address the unmet needs of rare diseases are lacking. In this study, we engaged with the community of Congenital Disorders of Glycosylation (CDG) to assess its needs and elicit social innovations to promote people-centred care and research.
Methods: Drawing on a qualitative study, we conducted three think tanks in France with a total of 48 participants, including patients/family members (n = 18), health care professionals (n = 7), researchers (n = 7) and people combining several of these roles (n = 16). Participants came from 20 countries across five continents. They were selected from the registry of the Second World Conference on CDG through heterogeneity and simple random sampling. Inductive and deductive approaches were employed to conduct interpretational analysis using open, axial and selective coding, and the constant-comparison method to facilitate the emergence of categories and core themes.
Results: The CDG community has unmet needs for information, quality health care, psychosocial support and representation in decision-making concerned with care and research. According to participants, these needs can be addressed through a range of social innovations, including peer-support communities, web-based information resources and a CDG expertise platform.
Conclusion: This is one of the few studies to engage lay and professional experts in needs assessment and innovation for CDG at a global level. Implementing the innovations proposed by the CDG community is likely to have ethical, legal and social implications associated with the potential donation of patients’ clinical and biological material that need to be assessed and regulated with involvement from all stakeholders. To promote people-centred care for the CDG community, and increase its participation in the governance of care and research, it is necessary to create participatory spaces in which the views of people affected by CDG can be fully expressed.
ER  -